Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
52.30
-0.04 (-0.08%)
At close: Jun 16, 2026, 4:00 PM EDT
51.72
-0.58 (-1.11%)
After-hours: Jun 16, 2026, 6:09 PM EDT

KNSA Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
214.27202.13180.86156.8137.79122.54112.21108.6379.8683.467.0571.4748.3561.8899.1426.9732.1918.7512.17.7
Revenue Growth (YoY)
55.51%64.95%61.17%44.34%72.54%46.93%67.37%51.99%65.18%34.76%-32.37%164.99%50.19%230.14%719.64%250.10%----
Cost of Revenue
20.820.9520.2618.617.8717.920.1112.3210.589.589.097.77.046.716.945.034.223.872.772.47
Gross Profit
193.47181.18160.6138.19119.92104.6492.1196.3169.2873.8157.9663.7741.3155.1792.221.9427.9714.889.335.24
Selling, General & Admin
61.1556.7849.146.8643.5340.5446.442.438.6836.7434.4729.1829.0527.2224.6823.8422.2222.7420.7621.85
Research & Development
27.4834.6124.1718.7519.3335.2226.0624.0226.3320.0517.1123.7715.1714.3916.4913.820.8227.4319.2423.95
Other Operating Expenses
75.5870.0363.3152.4243.7948.1929.3130.0120.816.9417.3113.998.297.524.623.678.250.84--
Total Operating Expenses
164.2161.41136.58118.03106.65123.94101.7696.4385.8273.7368.8966.9352.5149.1345.7941.3151.2951.014045.79
Operating Income
29.2719.7724.0220.1613.27-19.3-9.66-0.12-16.540.08-10.93-3.15-11.26.0546.41-19.37-23.32-36.13-30.67-40.56
Interest Income
------------------0.010.01
Other Non-Operating Income (Expense)
3.413.53.142.722.292.322.462.422.272.372.431.921.830.790.320.10.03---
Total Non-Operating Income (Expense)
3.413.53.142.722.292.322.462.422.272.372.431.921.830.790.320.10.03-0.010.01
Pretax Income
32.6823.2727.1622.8815.57-16.98-7.22.3-14.282.45-8.5-1.24-9.366.8446.74-19.27-23.29-36.05-30.66-40.55
Provision for Income Taxes
-10.09--8.72-5.05-7.03--5.49-6.21-3.4322.79-5.3616.21-2.91-2.38177.36-0.72-1.93-0.280.12-1.01
Net Income
22.5914.218.4417.838.54-8.89-12.69-3.91-17.725.24-13.8614.97-12.274.46224.09-19.98-25.21-36.33-30.54-41.56
Net Income to Common
22.5914.218.4417.838.54-8.89-12.69-3.91-17.725.24-13.8614.97-12.274.46224.09-19.98-25.21-36.33-30.54-41.56
Net Income Growth
164.57%--------465.73%----------
Shares Outstanding (Basic)
7776757373727271717070707070696969696968
Shares Outstanding (Diluted)
8282807876727271717370727071716969696968
Shares Change (YoY)
8.23%12.79%11.58%9.77%7.80%-0.47%2.20%-0.88%1.26%1.81%-0.52%3.38%0.89%3.48%2.75%1.31%1.27%1.33%4.10%18.10%
EPS (Basic)
0.300.190.250.240.12-0.12-0.18-0.06-0.250.36-0.200.21-0.180.063.23-0.29-0.36-0.53-0.44-0.61
EPS (Diluted)
0.270.170.230.230.11-0.12-0.18-0.06-0.250.35-0.200.21-0.180.063.18-0.29-0.36-0.53-0.44-0.61
EPS Growth
145.46%--------483.33%----------
Free Cash Flow
50.0453.2633.0127.9322.2318.58-2.245.173.94.2716.97-3.78-4.29-11.5462.03-7.94-36.85-19.14-28.56-38.84
Free Cash Flow Growth
125.14%186.70%-440.34%469.43%335.16%-----72.64%---------
Free Cash Flow Per Share
0.610.650.410.360.290.26-0.030.070.060.060.24-0.05-0.06-0.160.88-0.11-0.53-0.28-0.42-0.57
Gross Margin
90.29%89.64%88.80%88.14%87.03%85.40%82.08%88.66%86.75%88.51%86.45%89.23%85.45%89.16%93.00%81.35%86.89%79.37%77.12%67.99%
Operating Margin
13.66%9.78%13.28%12.86%9.63%-15.75%-8.61%-0.11%-20.71%0.10%-16.30%-4.41%-23.16%9.77%46.82%-71.81%-72.44%-192.75%-253.55%-526.41%
Profit Margin
10.54%7.02%10.19%11.37%6.20%-7.25%-11.31%-3.60%-22.17%30.26%-20.66%20.95%-25.38%7.21%226.05%-74.08%-78.32%-193.83%-252.53%-539.50%
FCF Margin
23.35%26.35%18.25%17.81%16.13%15.16%-1.99%4.76%4.89%5.12%25.31%-5.28%-8.88%-18.65%62.57%-29.43%-114.47%-102.08%-236.13%-504.18%
EBITDA
29.7420.2424.4120.5213.62-18.9-9.260.31-16.080.62-10.32-2.55-10.66.6546.91-18.72-22.66-35.46-30.01-39.84
EBITDA Margin
13.88%10.01%13.49%13.09%9.88%-15.42%-8.25%0.29%-20.13%0.74%-15.40%-3.57%-21.93%10.74%47.32%-69.39%-70.41%-189.19%-248.11%-517.11%
EBIT
29.2719.7724.0220.1613.27-19.3-9.66-0.12-16.540.08-10.93-3.15-11.26.0546.41-19.37-23.32-36.13-30.67-40.56
EBIT Margin
13.66%9.78%13.28%12.86%9.63%-15.75%-8.61%-0.11%-20.71%0.10%-16.30%-4.41%-23.16%9.77%46.82%-71.81%-72.44%-192.75%-253.55%-526.41%
Effective Tax Rate
-30.87%0.00%-32.12%-22.05%-45.14%0.00%76.27%-269.62%24.01%930.08%63.02%-1308.39%31.03%-34.79%379.50%3.72%8.27%0.77%-0.38%2.50%
SEC Filings: 10-K · 10-Q